amsacrine and Adenocarcinoma of Lung
amsacrine has been researched along with Adenocarcinoma of Lung in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Baguley, BC | 1 |
Drummond, CJ | 1 |
Chen, YY | 1 |
Finlay, GJ | 1 |
Reviews
1 review available for amsacrine and Adenocarcinoma of Lung
Article | Year |
---|---|
DNA-Binding Anticancer Drugs: One Target, Two Actions.
Topics: Adenocarcinoma of Lung; Amsacrine; Anaphase; Animals; Antineoplastic Agents; Chromatids; Chromosome | 2021 |